Literature DB >> 24041868

Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Neelu Puri1, Ryan T Pitman2, Richard E Mulnix2, Terrianne Erickson2, Audra N Iness2, Connie Vitali3, Yutong Zhao4, Ravi Salgia5.   

Abstract

Exposure of the telomere overhang acts as a DNA damage signal, and exogenous administration of an 11-base oligonucleotide homologous to the 3'-telomere overhang sequence (T-oligo) mimics the effects of overhang exposure by inducing senescence and cell death in non-small cell lung cancer (NSCLC) cells, but not in normal bronchial epithelial cells. T-oligo-induced decrease in cellular proliferation in NSCLC is likely directed through both p53 and its homolog, p73, with subsequent induction of senescence and expression of senescence-associated proteins, p21, p33(ING), and p27(Kip1) both in vivo and in vitro. Additionally, T-oligo decreases tumor size and inhibits angiogenesis through decreased VEGF signaling and increased TSP-1 expression.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Apoptosis; Lung cancer; Senescence; Telomere overhang; p53

Mesh:

Substances:

Year:  2013        PMID: 24041868      PMCID: PMC5839143          DOI: 10.1016/j.canlet.2013.09.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  65 in total

1.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2.

Authors:  J Karlseder; D Broccoli; Y Dai; S Hardy; T de Lange
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.

Authors:  Sibaji Sarkar; Douglas V Faller
Journal:  Oligonucleotides       Date:  2011-01-31

3.  E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.

Authors:  T F Kowalik; J DeGregori; G Leone; L Jakoi; J R Nevins
Journal:  Cell Growth Differ       Date:  1998-02

4.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

5.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

Authors:  B D Chang; E V Broude; M Dokmanovic; H Zhu; A Ruth; Y Xuan; E S Kandel; E Lausch; K Christov; I B Roninson
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

6.  The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

Authors:  I Garkavtsev; I A Grigorian; V S Ossovskaya; M V Chernov; P M Chumakov; A V Gudkov
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

Review 7.  Regulation of tumor angiogenesis by thrombospondin-1.

Authors:  Bin Ren; Karen O Yee; Jack Lawler; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2005-12-21

8.  Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.

Authors:  Mark S Eller; Guang-Zhi Li; Reza Firoozabadi; Neelu Puri; Barbara A Gilchrest
Journal:  FASEB J       Date:  2003-02       Impact factor: 5.191

9.  E2F-1 directly regulates thrombospondin 1 expression.

Authors:  Wei Ji; Wei Zhang; Wuhan Xiao
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

10.  Comparative analysis of p73 and p53 regulation and effector functions.

Authors:  L Fang; S W Lee; S A Aaronson
Journal:  J Cell Biol       Date:  1999-11-15       Impact factor: 10.539

View more
  10 in total

1.  T-oligo as an anticancer agent in colorectal cancer.

Authors:  Luke Wojdyla; Neelu Puri; Amanda L Stone; Nan Sethakorn; Srijayaprakash B Uppada; Joseph T Devito; Marc Bissonnette
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

Review 2.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

3.  Telomere Fragment Induced Amnion Cell Senescence: A Contributor to Parturition?

Authors:  Jossimara Polettini; Faranak Behnia; Brandie D Taylor; George R Saade; Robert N Taylor; Ramkumar Menon
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

4.  Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy.

Authors:  Srijayaprakash B Uppada; Terrianne Erickson; Luke Wojdyla; David N Moravec; Ziyuan Song; Jianjun Cheng; Neelu Puri
Journal:  Int J Nanomedicine       Date:  2013-12-17

Review 5.  Treating Cancer by Targeting Telomeres and Telomerase.

Authors:  Marko Ivancich; Zachary Schrank; Luke Wojdyla; Brandon Leviskas; Adijan Kuckovic; Ankita Sanjali; Neelu Puri
Journal:  Antioxidants (Basel)       Date:  2017-02-19

Review 6.  Telomeres and telomerase in oncogenesis.

Authors:  Tomasz Trybek; Artur Kowalik; Stanisław Góźdź; Aldona Kowalska
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

Review 7.  Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity.

Authors:  Ganiou Assani; Yudi Xiong; Fuxiang Zhou; Yunfeng Zhou
Journal:  Oncotarget       Date:  2018-10-09

8.  Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.

Authors:  Deven Etnyre; Amanda L Stone; Jason T Fong; Ryan J Jacobs; Srijayaprakash B Uppada; Gregory M Botting; Supriya Rajanna; David N Moravec; Manohar R Shambannagari; Zachary Crees; Jennifer Girard; Ceyda Bertram; Neelu Puri
Journal:  Cancer Biol Ther       Date:  2014-06-11       Impact factor: 4.742

Review 9.  Oligonucleotides Targeting Telomeres and Telomerase in Cancer.

Authors:  Zachary Schrank; Nabiha Khan; Chike Osude; Sanjana Singh; Rachel J Miller; Collin Merrick; Alexander Mabel; Adijan Kuckovic; Neelu Puri
Journal:  Molecules       Date:  2018-09-05       Impact factor: 4.411

Review 10.  Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies.

Authors:  Caroline Molinaro; Alain Martoriati; Katia Cailliau
Journal:  Cancers (Basel)       Date:  2021-07-29       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.